For example, administration of Stat3 reduces skeletal metastatic tumor growth and decreases skeletal tumor size, and CXCL5-deficient mice inhibit tumor progression, providing a clue for designing additional successful therapies.62 This evidence concerns the gene CXCL5 and neoplasm.